| Lars M Ellison, MD | |
|
3 Glen Cove Dr, Rockport, ME 04856-4232 | |
| (207) 593-5400 | |
| (207) 593-5301 |
| Full Name | Lars M Ellison |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 29 Years |
| Location | 3 Glen Cove Dr, Rockport, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114902749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | A83598 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penobscot Bay Medical Center | Rockport, ME | Hospital |
| Waldo County General Hospital | Belfast, ME | Hospital |
| Lincolnhealth | Damariscotta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
Aerosols and their spread play an essential role in the transmission of COVID-19. However, the risk of transmission could be significantly reduced if more could be done to reduce indoor airborne viruses.
A study published in the most recent issue of Academic Emergency Medicine (AEM), journal showed an increased risk of restraint use in Black patients compared with white patients in the emergency setting.
The world of microbes living in the human gut can have far-reaching effects on human health. Multiple diseases, including inflammatory bowel disease (IBD), are tied to the balance of these microbes, suggesting that restoring the right balance could help treat disease.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 6 days ago
| Entity Name | Waldo County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841397932 PECOS PAC ID: 2163332883 Enrollment ID: O20040428001058 |
News Archive
Aerosols and their spread play an essential role in the transmission of COVID-19. However, the risk of transmission could be significantly reduced if more could be done to reduce indoor airborne viruses.
A study published in the most recent issue of Academic Emergency Medicine (AEM), journal showed an increased risk of restraint use in Black patients compared with white patients in the emergency setting.
The world of microbes living in the human gut can have far-reaching effects on human health. Multiple diseases, including inflammatory bowel disease (IBD), are tied to the balance of these microbes, suggesting that restoring the right balance could help treat disease.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 6 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Aerosols and their spread play an essential role in the transmission of COVID-19. However, the risk of transmission could be significantly reduced if more could be done to reduce indoor airborne viruses.
A study published in the most recent issue of Academic Emergency Medicine (AEM), journal showed an increased risk of restraint use in Black patients compared with white patients in the emergency setting.
The world of microbes living in the human gut can have far-reaching effects on human health. Multiple diseases, including inflammatory bowel disease (IBD), are tied to the balance of these microbes, suggesting that restoring the right balance could help treat disease.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 6 days ago
| Entity Name | Penobscot Bay Physicians & Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497799720 PECOS PAC ID: 4981592383 Enrollment ID: O20040824000665 |
News Archive
Aerosols and their spread play an essential role in the transmission of COVID-19. However, the risk of transmission could be significantly reduced if more could be done to reduce indoor airborne viruses.
A study published in the most recent issue of Academic Emergency Medicine (AEM), journal showed an increased risk of restraint use in Black patients compared with white patients in the emergency setting.
The world of microbes living in the human gut can have far-reaching effects on human health. Multiple diseases, including inflammatory bowel disease (IBD), are tied to the balance of these microbes, suggesting that restoring the right balance could help treat disease.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lars M Ellison, MD 3 Glen Cove Dr, Rockport, ME 04856-4232 Ph: (207) 593-5400 | Lars M Ellison, MD 3 Glen Cove Dr, Rockport, ME 04856-4232 Ph: (207) 593-5400 |
News Archive
Aerosols and their spread play an essential role in the transmission of COVID-19. However, the risk of transmission could be significantly reduced if more could be done to reduce indoor airborne viruses.
A study published in the most recent issue of Academic Emergency Medicine (AEM), journal showed an increased risk of restraint use in Black patients compared with white patients in the emergency setting.
The world of microbes living in the human gut can have far-reaching effects on human health. Multiple diseases, including inflammatory bowel disease (IBD), are tied to the balance of these microbes, suggesting that restoring the right balance could help treat disease.
Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.
› Verified 6 days ago
Dr. Elizabeth A Albertson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Dr # 3, Rockport, ME 04856 Phone: 207-301-5400 | |
Martyn A Vickers Jr., M.D. Urology Medicare: Medicare Enrolled Practice Location: 3 Glen Cove Dr, Rockport, ME 04856 Phone: 207-593-5400 Fax: 207-593-5301 | |
Marshall Craig Hall, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Dr Ste 3, Rockport, ME 04856 Phone: 207-301-5400 | |
Dr. Sara L Valente, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3 Glen Cove Dr, Rockport, ME 04856 Phone: 201-301-5400 |